Microglia Sing the Prelude of Neuroinflammation-Associated Depression

Qingqing Li,Ying Xie,Jinyi Lin,Miaomiao Li,Ziyan Gu,Tianli Xin,Yang Zhang,Qixia Lu,Yihui Guo,Yanhong Xing,Wuyang Wang
DOI: https://doi.org/10.1007/s12035-024-04575-w
IF: 5.682
2024-11-17
Molecular Neurobiology
Abstract:Major depressive disorder (MDD) is a psychiatric condition characterized by sadness and anhedonia and is closely linked to chronic low-grade neuroinflammation, which is primarily induced by microglia. Nonetheless, the mechanisms by which microglia elicit depressive symptoms remain uncertain. This review focuses on the mechanism linking microglia and depression encompassing the breakdown of the blood–brain barrier, the hypothalamic–pituitary–adrenal axis, the gut-brain axis, the vagus and sympathetic nervous systems, and the susceptibility influenced by epigenetic modifications on microglia. These pathways may lead to the alterations of microglia in cytokine levels, as well as increased oxidative stress. Simultaneously, many antidepressant treatments can alter the immune phenotype of microglia, while anti-inflammatory treatments can also have antidepressant effects. This framework linking microglia, neuroinflammation, and depression could serve as a reference for targeting microglia to treat depression.
neurosciences
What problem does this paper attempt to address?